Prognostic value of inflammation-based prognostic scores in patients with colorectal cancer
Afonso, João Pedro Lima; Pereira, Ana; Pereira, Joaquim Costa; Martins, Sandra F.
J. coloproctol. (Rio J., Impr.)
; 41(4): 393-405, Out.-Dec. 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1356431
Documentos relacionados
The clinical value of C-reactive protein and its association with tumour location in patients undergoing curative surgery for colorectal cancer - a ScotScan collaborative study.
Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer.
Colorectal cancer clocks in on TIME.
Quantitative Metabolomics to Explore the Role of Plasma Polyamines in Colorectal Cancer.
Subtyping and prognostic model construction based on vesicle-mediated transport-related genes in colorectal cancer.
Postoperative Serum C-Reactive Protein Level Predicts Long-Term Outcomes in Colorectal Cancer Patients.
Immunological and prognostic significance of tumour necrosis in colorectal cancer.
Prognostic Assessment of Colorectal Cancer Patients after Laparoscopic Surgery: A Comprehensive Evaluation of the Glasgow Prognostic Score and Fibrinogen-to-Prealbumin Ratio.
C-reactive protein trajectories and the risk of all cancer types: A prospective cohort study.
Conflicting Guidelines: A Systematic Review on the Proper Interval for Colorectal Cancer Treatment.